Medistim ASA (LON:0OCD)

Market Cap	327.35M
Revenue (ttm)	45.32M
Net Income (ttm)	9.46M
Shares Out	n/a
EPS (ttm)	0.52
PE Ratio	34.60
Forward PE	29.86
Dividend	0.44 (0.19%)
Ex-Dividend Date	May 9, 2025

Volume	80
Average Volume	467
Open	233.00
Previous Close	225.00
Day's Range	233.00 - 233.00
52-Week Range	133.50 - 273.00
Beta	0.76
RSI	46.19
Earnings Date	Oct 24, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK